Works matching IS 02698811 AND DT 2024 AND VI 38 AND IP 9

Results: 8

Is lack of goal-conflict-specific rhythmicity a biomarker for treatment resistance in generalised anxiety but not social anxiety or major depression?

Published in:

Journal of Psychopharmacology, 2024, v. 38, n. 9, p. 789, doi. 10.1177/02698811241275627

By:

Shadli, Shabah M;
Donegan, Carina J;
Bin Mohd Fahmi, Muhammad SS;
Russell, Bruce R;
Glue, Paul;
McNaughton, Neil

Publication type:

Article

Safety, tolerability and pharmacokinetics of the phosphodiesterase 2 inhibitor BI 474121: An overview of phase I randomized trials in healthy volunteers.

Published in:

Journal of Psychopharmacology, 2024, v. 38, n. 9, p. 807, doi. 10.1177/02698811241273814

By:

Schaible, Jennifer;
Scholz, Andreas;
Goeldner, Rainer-Georg;
Yamamura, Norio

Publication type:

Article

Common protein networks for various drug regimens of major depression are associated with complement and immunity.

Published in:

Journal of Psychopharmacology, 2024, v. 38, n. 9, p. 798, doi. 10.1177/02698811241269683

By:

Lee, Seungyeon;
Mun, Sora;
Lee, Jiyeong;
Kang, Hee-Gyoo

Publication type:

Article

Insomnia and the effect of zolpidem-extended-release on the sleep items of the Hamilton Rating Scale for Depression in outpatients with depression, insomnia, and suicidal ideation: Relationship to patient age.

Published in:

Journal of Psychopharmacology, 2024, v. 38, n. 9, p. 827, doi. 10.1177/02698811241268900

By:

McCall, William V;
Mercado, Kayla;
Dzurny, Tess N;
McCloud, Laryssa L;
Krystal, Andrew D;
Benca, Ruth M;
Rosenquist, Peter B;
Looney, Stephen W

Publication type:

Article

Long-read sequencing of CYP2D6 may improve psychotropic prescribing and treatment outcomes: A systematic review and meta-analysis.

Published in:

Journal of Psychopharmacology, 2024, v. 38, n. 9, p. 771, doi. 10.1177/02698811241268899

By:

Kaptsis, Dean;
Lewis, Martin;
Sorich, Michael;
Battersby, Malcolm

Publication type:

Article

Re-visiting the association between antidepressant use and the risk of lung cancer.

Published in:

Journal of Psychopharmacology, 2024, v. 38, n. 9, p. 832, doi. 10.1177/02698811241268887

By:

Sun, Ching-Fang;
Su, Kuan-Pin;
Kablinger, Anita S

Publication type:

Article

Evidence-based guidelines for the interpretation of the 9-item Concise Health Risk Tracking – Self-Report (CHRT-SR<sub>9</sub>) measure of suicidal risk.

Published in:

Journal of Psychopharmacology, 2024, v. 38, n. 9, p. 784, doi. 10.1177/02698811241268875

By:

Nandy, Karabi;
Nandy, Rajesh Ranjan;
Rush, A John;
Mayes, Taryn L;
Trivedi, Madhukar H

Publication type:

Article

Beneficial adjunctive effects of the 5HT3 receptor antagonist ondansetron on symptoms, function and cognition in early phase schizophrenia in a double-blind, 2 × 2 factorial design, randomised controlled comparison with simvastatin.

Published in:

Journal of Psychopharmacology, 2024, v. 38, n. 9, p. 818, doi. 10.1177/02698811241267836

By:

Chaudhry, Imran B;
Husain, Muhammad Omair;
Khoso, Ameer B;
Kiran, Tayyeba;
Husain, Muhammad Ishrat;
Qurashi, Inti;
Rahman, Raza Ur;
Mehmood, Nasir;
Drake, Richard;
Husain, Nusrat;
Deakin, Bill

Publication type:

Article